- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/76 - TrypsinChymotrypsin
Patent holdings for IPC class C12N 9/76
Total number of patents in this class: 108
10-year publication summary
|
7
|
11
|
10
|
12
|
6
|
9
|
12
|
8
|
12
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sanofi-Aventis Deutschland GmbH | 2630 |
6 |
| Enzymatica AB | 30 |
5 |
| Carnegie Mellon University | 1528 |
4 |
| Merck Sharp & Dohme Corp. | 2200 |
3 |
| Novozymes A/S | 3318 |
3 |
| Vertex Pharmaceuticals Incorporated | 1598 |
3 |
| BioPharma Translationsinstitut Dessau Forschungs GmbH | 4 |
3 |
| Merck Millipore Ltd. | 35 |
3 |
| Nestec S.A. | 2672 |
2 |
| Amgen Inc. | 4074 |
2 |
| The Johns Hopkins University | 5659 |
2 |
| Burcon NutraScience (MB) Corp. | 136 |
2 |
| Tokyo University of Science Foundation | 388 |
2 |
| Waters Technologies Corporation | 1694 |
2 |
| Guangdong Ocean University | 161 |
2 |
| Cytiva Sweden AB | 763 |
2 |
| Endsulin, Inc. | 6 |
2 |
| St. Marie Intellectual Property Holdings, LLC | 2 |
2 |
| Merck Sharp & Dohme LLC | 3749 |
2 |
| Pontis Biologics, Inc. | 3 |
2 |
| Other owners | 54 |